Advisors Preferred, LLC Lantheus Holdings, Inc. Transaction History

Advisors Preferred, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2019 Jan 21, 2020	SELL	$18.47 - $24.03 $8,366 - $10,885	-453 Closed	0 $0
Q3 2019 Nov 12, 2019	BUY	$21.01 - $28.94 $9,517 - $13,109	453 New	453 $11,000
Q2 2018 Aug 07, 2018	SELL	$13.65 - $18.7 $27,955 - $38,297	-2,048 Closed	0 $0
Q1 2018 Apr 30, 2018	BUY	$14.85 - $24.3 $30,412 - $49,766	2,048 New	2,048 $33,000

495

67.2M

1.19M

829K

Ticker LNTH
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 68,741,904
Market Cap $7.33B
Description
Lantheus Holdings, Inc. develops, manufactures, and commercializes diagnostic and therapeutic products that assist clinicians in the diagnosis and treatment of heart, cancer, and other diseases worldwide. It provides DEFINITY, a microbubble ultrasound enhancing agent used in ultrasound exams of the heart; TechneLite, a technetium generator for n...

Get notified when there are updates to the investment portfolio of Advisors Preferred, LLC, based on Form 13F filings with the SEC.

Stay updated on Advisors Preferred, LLC with notifications on news.